Pfeilstöcker M - Search Results

1

The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.

Geissler K, Jäger E, Barna A, Gurbisz M, Marschon R, Graf T, Graf E, Borjan B, Jilch R, Geissler C, Hoermann G, Esterbauer H, Schwarzinger I, Nösslinger T, Pfeilstöcker M, Tüchler H, Reisner R, Sliwa T, Keil F, Bettelheim P, Machherndl-Spandl S, Doleschal B, Zach O, Weltermann A, Heibl S, Thaler J, Zebisch A, Sill H, Stauder R, Webersinke G, Petzer A, Kusec R, Ulsperger E, Schneeweiss B, Berger J, Öhler L, Germing U, Sperr WR, Knöbl P, Jäger U, Valent P. Geissler K, et al. Among authors: pfeilstocker m. Wien Klin Wochenschr. 2019 Sep;131(17-18):410-418. doi: 10.1007/s00508-019-1526-1. Epub 2019 Jul 18. Wien Klin Wochenschr. 2019. PMID: 31321531 Free PMC article.

2

Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.

Ravandi F, Döhner H, Wei AH, Montesinos P, Pfeilstöcker M, Papayannidis C, Lai Y, Wang K, See WL, de Menezes DL, Petrlik E, Prebet T, Roboz GJ. Ravandi F, et al. Among authors: pfeilstocker m. Br J Haematol. 2024 Mar;204(3):877-886. doi: 10.1111/bjh.19202. Epub 2023 Nov 12. Br J Haematol. 2024. PMID: 37952982

3

[Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia].

Pfeilstöcker M, Waldner R, Reisner R, Heinz R, Pittermann E. Pfeilstöcker M, et al. Infusionsther Transfusionsmed. 1995 Aug;22(4):220-4. Infusionsther Transfusionsmed. 1995. PMID: 7496120 German.

4

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

Pfeilstöcker M, Reisner R, Nösslinger T, Grüner H, Nowotny H, Tüchler H, Schlögl E, Pittermann E, Heinz R. Pfeilstöcker M, et al. Br J Haematol. 1999 Aug;106(2):455-63. doi: 10.1046/j.1365-2141.1999.01559.x. Br J Haematol. 1999. PMID: 10460606 Free article.

5

Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).

Karlic H, Louda N, Pfeilstöcker M, Keil F, Lohninger A, Pittermann E, Paukovits J. Karlic H, et al. Among authors: pfeilstocker m. Stem Cells. 2001;19(4):321-8. doi: 10.1634/stemcells.19-4-321. Stem Cells. 2001. PMID: 11463952

6

Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.

Nösslinger T, Reisner R, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M. Nösslinger T, et al. Among authors: pfeilstocker m. Leuk Res. 2001 Sep;25(9):741-7. doi: 10.1016/s0145-2126(01)00014-5. Leuk Res. 2001. PMID: 11489467

7

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M. Nösslinger T, et al. Among authors: pfeilstocker m. Blood. 2001 Nov 15;98(10):2935-41. doi: 10.1182/blood.v98.10.2935. Blood. 2001. PMID: 11698274 Free article.

8

Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Galpha16 and 5'-lipoxygenase.

Pfeilstöcker M, Karlic H, Nösslinger T, Tüchler H, Lohninger A, Pittermann E. Pfeilstöcker M, et al. Ann Hematol. 2002 Nov;81(11):632-40. doi: 10.1007/s00277-002-0536-6. Epub 2002 Oct 23. Ann Hematol. 2002. PMID: 12454701

9

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.

Kaufmann H, Ackermann J, Baldia C, Nösslinger T, Wieser R, Seidl S, Sagaster V, Gisslinger H, Jäger U, Pfeilstöcker M, Zielinski C, Drach J. Kaufmann H, et al. Among authors: pfeilstocker m. Leukemia. 2004 Nov;18(11):1879-82. doi: 10.1038/sj.leu.2403518. Leukemia. 2004. PMID: 15385925

10

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

Germing U, Hildebrandt B, Pfeilstöcker M, Nösslinger T, Valent P, Fonatsch C, Lübbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis AA, Strupp C, Kündgen A, Mueller T, Haas R, Gattermann N, Aul C. Germing U, et al. Among authors: pfeilstocker m. Leukemia. 2005 Dec;19(12):2223-31. doi: 10.1038/sj.leu.2403963. Leukemia. 2005. PMID: 16193087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page